688710 益诺思
已收盘 07-03 15:00:02
资讯
新帖
简况
每周股票复盘:益诺思(688710)增补两名非独立董事
证券之星 · 07-05 03:06
每周股票复盘:益诺思(688710)增补两名非独立董事
益诺思(688710)披露2026年第一次临时股东会决议公告,6月30日股价下跌1.29%
证券之星 · 06-30
益诺思(688710)披露2026年第一次临时股东会决议公告,6月30日股价下跌1.29%
6月29日益诺思涨5.24%,平安医疗健康混合A基金重仓该股
证券之星 · 06-29
6月29日益诺思涨5.24%,平安医疗健康混合A基金重仓该股
每周股票复盘:益诺思(688710)将召开临时股东会审议董事薪酬及增补两名非独立董事
证券之星 · 06-28
每周股票复盘:益诺思(688710)将召开临时股东会审议董事薪酬及增补两名非独立董事
益诺思(688710)披露2026年第一次临时股东会会议资料,6月24日股价上涨3.95%
证券之星 · 06-24
益诺思(688710)披露2026年第一次临时股东会会议资料,6月24日股价上涨3.95%
益诺思涨5.22%,开源证券二个月前给出“买入”评级
证券之星 · 06-22
益诺思涨5.22%,开源证券二个月前给出“买入”评级
益诺思涨6.49%,开源证券二个月前给出“买入”评级
证券之星 · 06-18
益诺思涨6.49%,开源证券二个月前给出“买入”评级
6月8日益诺思跌9.06%,平安医疗健康混合A基金重仓该股
证券之星 · 06-08
6月8日益诺思跌9.06%,平安医疗健康混合A基金重仓该股
每周股票复盘:益诺思(688710)2025年度股东会多项议案获通过
证券之星 · 05-31
每周股票复盘:益诺思(688710)2025年度股东会多项议案获通过
益诺思(688710)披露2025年年度股东会决议公告,5月29日股价下跌1.64%
证券之星 · 05-29
益诺思(688710)披露2025年年度股东会决议公告,5月29日股价下跌1.64%
每周股票复盘:益诺思(688710)股东询价转让价格确定为58.25元/股
证券之星 · 05-24
每周股票复盘:益诺思(688710)股东询价转让价格确定为58.25元/股
益诺思(688710)披露持股5%以上股东权益变动至5%以下公告,5月21日股价上涨1.71%
证券之星 · 05-21
益诺思(688710)披露持股5%以上股东权益变动至5%以下公告,5月21日股价上涨1.71%
益诺思(688710.SH)子公司南通益诺思获得NMPA GLP认证
智通财经 · 05-21
益诺思(688710.SH)子公司南通益诺思获得NMPA GLP认证
益诺思(688710)披露2025年年度股东会会议资料,5月19日股价下跌3.55%
证券之星 · 05-19
益诺思(688710)披露2025年年度股东会会议资料,5月19日股价下跌3.55%
益诺思(688710)披露股东询价转让定价情况提示性公告,5月18日股价上涨1.79%
证券之星 · 05-18
益诺思(688710)披露股东询价转让定价情况提示性公告,5月18日股价上涨1.79%
股市必读:5月15日益诺思发生2笔大宗交易 成交金额494.76万元
证券之星 · 05-18
股市必读:5月15日益诺思发生2笔大宗交易 成交金额494.76万元
每周股票复盘:益诺思(688710)股东拟减持2.50%股份
证券之星 · 05-17
每周股票复盘:益诺思(688710)股东拟减持2.50%股份
益诺思(688710)2026年一季报简析:营收净利润同比双双增长,存货明显上升
证券之星 · 05-01
益诺思(688710)2026年一季报简析:营收净利润同比双双增长,存货明显上升
益诺思(688710)3月31日股东户数0.41万户,较上期减少12.56%
证券之星 · 04-30
益诺思(688710)3月31日股东户数0.41万户,较上期减少12.56%
图解益诺思年报:第四季度单季净利润同比下降204.90%
证券之星 · 04-30
图解益诺思年报:第四季度单季净利润同比下降204.90%
暂无数据
公司概况
公司名称:
上海益诺思生物技术股份有限公司
所属行业:
研究和试验发展
上市日期:
2024-09-03
主营业务:
上海益诺思生物技术股份有限公司的主营业务是提供生物医药非临床研究服务为主的综合研发服务(CRO)。公司的主要产品是非临床CRO、临床CRO。公司荣膺医药魔方“中国创新药十年荣耀榜·行业引领CRO公司”、药融圈“中国新药临床前CRO排名TOP20”、每日经济新闻“2025上市公司最具社会责任奖”、《证券市场周刊》“金曙光新质生产力奖”等系列荣誉,并凭借在体内CAR-T领域的突出贡献,成为同写意“体内CAR-T新基建联盟成员机构”;同时获评石药集团“2025最佳合作单位”。
发行价格:
19.06
{"stockData":{"symbol":"688710","market":"SH","secType":"STK","nameCN":"益诺思","latestPrice":62.67,"timestamp":1783062002000,"preClose":65,"halted":0,"volume":4273171,"delay":0,"changeRate":-0.0358,"floatShares":90694000,"shares":141000000,"eps":-0.1691,"marketStatus":"已收盘","change":-2.33,"latestTime":"07-03 15:00:02","open":67.29,"high":67.86,"low":60.09,"amount":266000000,"amplitude":0.1195,"askPrice":62.7,"askSize":9,"bidPrice":62.67,"bidSize":10,"shortable":0,"etf":0,"ttmEps":-0.1691,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783301400000},"marketStatusCode":5,"adr":0,"adjPreClose":65,"symbolType":"stock_kcb","openAndCloseTimeList":[[1783042200000,1783049400000],[1783054800000,1783062000000]],"highLimit":71.5,"lowLimit":58.5,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":140979615,"isCdr":false,"pbRate":3.78,"roa":"--","roe":"0.52%","epsLYR":-0.22,"committee":0.393939,"marketValue":8835000000,"turnoverRate":0.0471,"status":1,"afterMarket":{"amount":0,"volume":0,"close":62.67,"buyVolume":0,"sellVolume":100,"time":1783064037746,"indexStatus":"已收盘 07-03 15:30:00","preClose":65},"floatMarketCap":5684000000},"requestUrl":"/m/hq/s/688710/tweets","defaultTab":"tweets","newsList":[{"id":"2649053694","title":"每周股票复盘:益诺思(688710)增补两名非独立董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2649053694","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649053694?lang=zh_cn&edition=full","pubTime":"2026-07-05 03:06","pubTimestamp":1783191974,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,益诺思报收于62.67元,较上周的64.69元下跌3.12%。本周,益诺思7月2日盘中最高价报71.0元。本周关注点公司公告汇总:增补高莉、翁少羽为非独立董事。上海益诺思生物技术股份有限公司于2026年6月29日召开2026年第一次临时股东会,审议通过《董事、高级管理人员薪酬管理制度》议案,并增补高莉女士、翁少羽女士为非独立董事。所有议案均获通过,无反对或弃权情况。中小投资者对董事增补议案进行了单独计票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500000960.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647522534","title":"益诺思(688710)披露2026年第一次临时股东会决议公告,6月30日股价下跌1.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647522534","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647522534?lang=zh_cn&edition=full","pubTime":"2026-06-30 17:50","pubTimestamp":1782813055,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘,益诺思报收于67.2元,较前一交易日下跌1.29%,最新总市值为94.74亿元。该股当日开盘66.66元,最高69.5元,最低65.78元,成交额达2.11亿元,换手率为3.42%。公司于近日披露《2026年第一次临时股东会决议公告》。公告显示,上海益诺思生物技术股份有限公司于2026年6月29日召开2026年第一次临时股东会,审议通过《董事、高级管理人员薪酬管理制度》议案,并增补高莉女士、翁少羽女士为非独立董事。所有议案均获通过,无反对或弃权情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000033433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647322677","title":"6月29日益诺思涨5.24%,平安医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647322677","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647322677?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:47","pubTimestamp":1782722824,"startTime":"0","endTime":"0","summary":"证券之星消息,6月29日益诺思涨5.24%,收盘报68.08元,换手率3.78%,成交量3.43万手,成交额2.29亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共32家,其中持有数量最多的公募基金为平安基金的平安医疗健康混合A。平安医疗健康混合A目前规模为17.03亿元,最新净值1.9606,较上一交易日下跌2.45%,近一年下跌20.04%。平安医疗健康混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","159760","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646315547","title":"每周股票复盘:益诺思(688710)将召开临时股东会审议董事薪酬及增补两名非独立董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2646315547","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646315547?lang=zh_cn&edition=full","pubTime":"2026-06-28 03:14","pubTimestamp":1782587654,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,益诺思报收于64.69元,较上周的57.12元上涨13.25%。本周,益诺思6月26日盘中最高价报67.47元。本周关注点公司公告汇总:益诺思将召开2026年第一次临时股东会,审议董事、高管薪酬制度,并就增补高莉、翁少羽为非独立董事进行表决。因魏树源、陆伟根到龄退休,张勇因工作调整辞去董事职务,董事会提名高莉女士、翁少羽女士为非独立董事候选人,采用累积投票制选举。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645997698","title":"益诺思(688710)披露2026年第一次临时股东会会议资料,6月24日股价上涨3.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645997698","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645997698?lang=zh_cn&edition=full","pubTime":"2026-06-24 17:47","pubTimestamp":1782294449,"startTime":"0","endTime":"0","summary":"截至2026年6月24日收盘,益诺思报收于63.61元,较前一交易日上涨3.95%,最新总市值为89.68亿元。该股当日开盘61.08元,最高65.8元,最低60.04元,成交额达2.32亿元,换手率为4.0%。近日,益诺思披露《2026年第一次临时股东会会议资料》。公告显示,公司将于2026年6月29日以现场与网络投票相结合方式召开2026年第一次临时股东会,审议《董事、高级管理人员薪酬管理制度》议案,并就增补非独立董事事项进行表决。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400033098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645304090","title":"益诺思涨5.22%,开源证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2645304090","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645304090?lang=zh_cn&edition=full","pubTime":"2026-06-22 16:41","pubTimestamp":1782117689,"startTime":"0","endTime":"0","summary":"今日益诺思涨5.22%,收盘报60.1元。2026年3月26日,开源证券研究员余汝意发布了对益诺思的研报《公司首次覆盖报告:国资赋能的临床前CRO领先企业》,该研报对益诺思给出“买入”评级。当前股价对应2025-2027年PE分别为-242.11/63.42/38.46倍,首次覆盖,给予“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为长江证券的万梦蝶、彭英骐。益诺思个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200023667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644303706","title":"益诺思涨6.49%,开源证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2644303706","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644303706?lang=zh_cn&edition=full","pubTime":"2026-06-18 16:37","pubTimestamp":1781771872,"startTime":"0","endTime":"0","summary":"今日益诺思涨6.49%,收盘报57.12元。2026年3月26日,开源证券研究员余汝意发布了对益诺思的研报《公司首次覆盖报告:国资赋能的临床前CRO领先企业》,该研报对益诺思给出“买入”评级。当前股价对应2025-2027年PE分别为-242.11/63.42/38.46倍,首次覆盖,给予“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为长江证券的万梦蝶、彭英骐。益诺思个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800028780.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641910712","title":"6月8日益诺思跌9.06%,平安医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641910712","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641910712?lang=zh_cn&edition=full","pubTime":"2026-06-08 16:47","pubTimestamp":1780908479,"startTime":"0","endTime":"0","summary":"证券之星消息,6月8日益诺思跌9.06%,收盘报51.8元,换手率3.59%,成交量3.26万手,成交额1.73亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共32家,其中持有数量最多的公募基金为平安基金的平安医疗健康混合A。平安医疗健康混合A目前规模为17.03亿元,最新净值1.8687,较上一交易日下跌1.53%,近一年下跌20.24%。平安医疗健康混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800022335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","159760","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639604577","title":"每周股票复盘:益诺思(688710)2025年度股东会多项议案获通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2639604577","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639604577?lang=zh_cn&edition=full","pubTime":"2026-05-31 03:06","pubTimestamp":1780167974,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘,益诺思报收于60.51元,较上周的64.82元下跌6.65%。本周关注点公司公告汇总:2025年年度股东会审议通过利润分配方案、“十五五”发展规划等多项议案。公司公告汇总上海益诺思生物技术股份有限公司于2026年5月29日召开2025年年度股东会,采用现场与网络投票相结合的方式,审议通过《2025年度董事会工作报告》、2025年度利润分配方案、“十五五”发展规划、2026年度日常关联交易预计及董事2025年度薪酬等议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000845.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639673730","title":"益诺思(688710)披露2025年年度股东会决议公告,5月29日股价下跌1.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639673730","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639673730?lang=zh_cn&edition=full","pubTime":"2026-05-29 22:25","pubTimestamp":1780064717,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘,益诺思报收于60.51元,较前一交易日下跌1.64%,最新总市值为85.31亿元。该股当日开盘61.51元,最高64.5元,最低58.0元,成交额达1.59亿元,换手率为2.88%。近日,上海益诺思生物技术股份有限公司披露《2025年年度股东会决议公告》。所有议案均获通过,无反对或弃权情况。出席会议股东所持表决权占公司总表决权的53.6661%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900046365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637760543","title":"每周股票复盘:益诺思(688710)股东询价转让价格确定为58.25元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2637760543","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637760543?lang=zh_cn&edition=full","pubTime":"2026-05-24 05:31","pubTimestamp":1779571870,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘,益诺思报收于64.82元,较上周的64.67元上涨0.23%。本次询价转让拟转让股份已获全额认购,初步确定受让方为14家机构投资者,拟受让股份总数为3,528,094股。国泰海通证券作为组织券商,对上海益诺思生物技术股份有限公司股东张江生药基地向特定机构投资者询价转让股份事项出具核查报告。本次权益变动前,持有益诺思7.82%股份;变动后持有6,082,863股,占总股本4.31%,持股比例降至5%以下。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637337537","title":"益诺思(688710)披露持股5%以上股东权益变动至5%以下公告,5月21日股价上涨1.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637337537","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637337537?lang=zh_cn&edition=full","pubTime":"2026-05-21 22:50","pubTimestamp":1779375023,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘,益诺思报收于65.41元,较前一交易日上涨1.71%,最新总市值为92.21亿元。该股当日开盘65.08元,最高68.7元,最低63.68元,成交额达2.1亿元,换手率为3.46%。近日,公司披露《股东询价转让结果报告书暨持股5%以上股东持有权益比例降至5%以下的提示性公告》。国泰海通证券对本次转让出具核查意见,认为程序合法合规。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100044850.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637811953","title":"益诺思(688710.SH)子公司南通益诺思获得NMPA GLP认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2637811953","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637811953?lang=zh_cn&edition=full","pubTime":"2026-05-21 17:49","pubTimestamp":1779356985,"startTime":"0","endTime":"0","summary":"智通财经APP讯,益诺思(688710.SH)发布公告,公司全资子公司益诺思生物技术南通有限公司(以下简称“南通益诺思”)的“高品质非临床创新药物综合评价平台扩建项目”顺利通过国家药品监督管理局(以下简称“NMPA”)GLP检查,并收到NMPA颁发的《药物GLP认证证书》。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444558.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688710","BK0216","GLP","BK4144","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636985712","title":"益诺思(688710)披露2025年年度股东会会议资料,5月19日股价下跌3.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636985712","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636985712?lang=zh_cn&edition=full","pubTime":"2026-05-19 22:47","pubTimestamp":1779202032,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘,益诺思报收于63.49元,较前一交易日下跌3.55%,最新总市值为89.51亿元。该股当日开盘67.15元,最高69.7元,最低62.99元,成交额达1.56亿元,换手率为2.6%。近日,上海益诺思生物技术股份有限公司披露《2025年年度股东会会议资料》。公告显示,公司拟召开2025年年度股东会,审议2025年度董事会工作报告、利润分配方案、“十五五”发展规划、2026年度日常关联交易预计及董事2025年度薪酬等议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900044257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636279690","title":"益诺思(688710)披露股东询价转让定价情况提示性公告,5月18日股价上涨1.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636279690","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636279690?lang=zh_cn&edition=full","pubTime":"2026-05-18 18:57","pubTimestamp":1779101833,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘,益诺思报收于65.83元,较前一交易日上涨1.79%,最新总市值为92.81亿元。该股当日开盘65.25元,最高68.72元,最低63.02元,成交额达1.93亿元,换手率为3.21%。近日,公司披露《股东询价转让定价情况提示性公告》。参与报价的机构投资者共32家,有效认购股份数量为7,488,000股,有效认购倍数约为2.12倍。本次询价转让拟转让股份已获全额认购,初步确定受让方为14家机构投资者,拟受让股份总数为3,528,094股。本次转让不涉及公司控制权变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800030100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636016969","title":"股市必读:5月15日益诺思发生2笔大宗交易 成交金额494.76万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2636016969","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636016969?lang=zh_cn&edition=full","pubTime":"2026-05-18 04:01","pubTimestamp":1779048076,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,益诺思报收于64.67元,上涨2.29%,换手率2.46%,成交量2.23万手,成交额1.45亿元。大宗交易5月15日益诺思发生2笔大宗交易,成交金额494.76万元。股东询价转让计划书上海益诺思生物技术股份有限公司股东张江生药基地拟通过询价转让方式减持公司股份3,528,094股,占公司总股本的2.50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800001660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636064245","title":"每周股票复盘:益诺思(688710)股东拟减持2.50%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2636064245","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636064245?lang=zh_cn&edition=full","pubTime":"2026-05-17 03:39","pubTimestamp":1778960350,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,益诺思报收于64.67元,较上周的65.12元下跌0.69%。本周,益诺思5月15日盘中最高价报67.05元。出让方为合法存续的国有控股企业,非益诺思控股股东或董监高,拟转让股份为首发前股份且无质押、冻结等权利受限情形,已履行必要审批程序,符合《询价转让和配售指引》规定的相关资格要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632660266","title":"益诺思(688710)2026年一季报简析:营收净利润同比双双增长,存货明显上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2632660266","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632660266?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:52","pubTimestamp":1777589548,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期益诺思发布2026年一季报。截至本报告期末,公司营业总收入2.1亿元,同比上升0.43%,归母净利润1220.86万元,同比上升121.23%。本报告期益诺思存货明显上升,存货同比增幅达34.32%。持有益诺思最多的基金为平安医疗健康混合A,目前规模为17.03亿元,最新净值2.2908,较上一交易日下跌1.07%,近一年上涨7.9%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100007461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631684968","title":"益诺思(688710)3月31日股东户数0.41万户,较上期减少12.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631684968","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631684968?lang=zh_cn&edition=full","pubTime":"2026-04-30 17:36","pubTimestamp":1777541761,"startTime":"0","endTime":"0","summary":"证券之星消息,近日益诺思披露,截至2026年3月31日公司股东户数为4079.0户,较12月31日减少586.0户,减幅为12.56%。在医疗服务行业个股中,益诺思股东户数低于行业平均水平,截至3月31日,医疗服务行业平均股东户数为4.9万户。从股价来看,2025年12月31日至2026年3月31日,益诺思区间涨幅为60.82%,在此期间股东户数减少586.0户,减幅为12.56%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000056629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631544291","title":"图解益诺思年报:第四季度单季净利润同比下降204.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631544291","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631544291?lang=zh_cn&edition=full","pubTime":"2026-04-30 01:01","pubTimestamp":1777482117,"startTime":"0","endTime":"0","summary":"证券之星消息,益诺思2025年年报显示,当年度公司主营收入8.11亿元,同比下降28.94%;归母净利润-3051.59万元,同比下降120.65%;扣非净利润-5389.68万元,同比下降142.98%;其中2025年第四季度,公司单季度主营收入2.41亿元,同比下降7.17%;单季度归母净利润-1572.78万元,同比下降204.9%;单季度扣非净利润-1913.74万元,同比下降506.29%;负债率27.4%,财务费用-850.09万元,毛利率25.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000003262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688710"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783282462131,"stockEarnings":[{"period":"1week","weight":-0.0312},{"period":"1month","weight":0.0649},{"period":"3month","weight":-0.0688},{"period":"6month","weight":0.4195},{"period":"1year","weight":0.8327},{"period":"ytd","weight":0.4195}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0421},{"period":"6month","weight":0.0188},{"period":"1year","weight":0.1683},{"period":"ytd","weight":0.0188}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海益诺思生物技术股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"4079人(较上一季度减少12.56%)","perCapita":"22234股","listingDate":"2024-09-03","address":"上海市浦东新区中国(上海)自由贸易试验区郭守敬路199号106室","registeredCapital":"14097万元","survey":" 上海益诺思生物技术股份有限公司的主营业务是提供生物医药非临床研究服务为主的综合研发服务(CRO)。公司的主要产品是非临床CRO、临床CRO。公司荣膺医药魔方“中国创新药十年荣耀榜·行业引领CRO公司”、药融圈“中国新药临床前CRO排名TOP20”、每日经济新闻“2025上市公司最具社会责任奖”、《证券市场周刊》“金曙光新质生产力奖”等系列荣誉,并凭借在体内CAR-T领域的突出贡献,成为同写意“体内CAR-T新基建联盟成员机构”;同时获评石药集团“2025最佳合作单位”。","listedPrice":19.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"益诺思(688710)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供益诺思(688710)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"益诺思,688710,益诺思股票,益诺思股票老虎,益诺思股票老虎国际,益诺思行情,益诺思股票行情,益诺思股价,益诺思股市,益诺思股票价格,益诺思股票交易,益诺思股票购买,益诺思股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"益诺思(688710)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供益诺思(688710)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}